APA (7th ed.) Citation

Ong, T. A., Abd Ghafar, N. K., Alip, A., Yap, N. Y., & Saad, M. (2018). Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience. Medknow Publications.

Chicago Style (17th ed.) Citation

Ong, Teng Aik, Nahjatul Kursyiah Abd Ghafar, Adlinda Alip, Ning Yi Yap, and Marniza Saad. Efficacy, Safety, and Prognostic Indicators of First-line Sunitinib in Patients with Metastatic Renal Cell Carcinoma: A Single Center Experience. Medknow Publications, 2018.

MLA (9th ed.) Citation

Ong, Teng Aik, et al. Efficacy, Safety, and Prognostic Indicators of First-line Sunitinib in Patients with Metastatic Renal Cell Carcinoma: A Single Center Experience. Medknow Publications, 2018.